118th Congress (2023–2025) · House bill · Sponsor: Rep. De La Cruz, Monica [R-TX-15]
This page covers HR1076 in the 118th Congress. Bill numbers start over every Congress, so HR1076 in another Congress is a different bill.
| Item | Detail |
|---|---|
| Roll-call votes | 1 |
| Chamber | House |
| Latest vote | 2023-05-22: Passed |
| Latest action | 2024-09-13: Became Public Law No: 118-79. |
| Policy area | Government Operations and Politics |
| Official record | Congress.gov |
Preventing the Financing of Illegal Synthetic Drugs Act This bill requires the Government Accountability Office to carry out a study on illicit financing in connection with the trafficking of synthetic drugs, including fentanyl and methamphetamine, fentanyl- and methamphetamine-related substances, Captagon, and fentanyl and methamphetamine precursors, and to report to Congress.
Subjects: Congressional oversight, Drug trafficking and controlled substances, Fraud offenses and financial crimes, Government studies and investigations, Internet, web applications, social media, Smuggling and trafficking
Every recorded vote on this bill, newest first, with a link to the official tally. Member-by-member positions are on each member’s profile.
| Date | Chamber | Question | Result | Yea | Nay | Not voting | Record |
|---|---|---|---|---|---|---|---|
| 2023-05-22 | House | 2/3 Yea-And-Nay | Passed | 338 | 1 | 24 | Official tally |
HR1076 (Preventing the Financing of Illegal Synthetic Drugs Act) was introduced in the 118th Congress (2023–2025) by Rep. De La Cruz, Monica [R-TX-15].
On 2024-09-13: Became Public Law No: 118-79.
1 recorded vote in the 118th Congress. The most recent, on 2023-05-22, was "2/3 Yea-And-Nay": Passed.